UpHill is a technology company.
UpHill has raised $8.0M across 1 funding round.
UpHill has raised $8.0M in total across 1 funding round.
UpHill has raised $8.0M in total across 1 funding round.
UpHill's investors include Brighteye Ventures, Speedinvest, Nicolas Steegmann, Thibaud Elziere.
UpHill is a Lisbon-based health tech company developing a B2B SaaS platform that streamlines healthcare processes to enhance patient care.[3] It serves healthcare organizations by automating workflows, supporting clinical decision-making, and coordinating care journeys, addressing inefficiencies in care orchestration beyond basic telemonitoring.[2][3] The platform has achieved European Class IIa medical device certification through rigorous independent audits, ensuring high standards of safety and quality—distinguishing it from simpler Class I self-declared options.[2] UpHill has raised $8.3 million across two funding rounds from six investors, signaling strong growth momentum in the competitive health tech sector.[3]
UpHill emerged in Lisbon as a health tech startup focused on B2B SaaS for healthcare process optimization, though specific founding year and founder details are not detailed in available records.[3] A pivotal moment came with its achievement of European Class IIa medical device certification, highlighting its early commitment to complex care orchestration features like workflow automation and team coordination, which underwent in-depth audits by EU-designated bodies.[2] This certification underscores rapid traction in regulatory compliance, positioning UpHill as a reliable partner for healthcare transformation amid rising demands for advanced, compliant digital tools.[1][2]
(Note: Search results do not specify exact founders or initial idea origins; it is distinct from older entities like Uphill Technologies Limited, a UK ICT consultancy founded around 2010.[4])
UpHill rides the wave of digital health transformation, where AI-driven care orchestration meets post-pandemic demands for efficient, coordinated patient management.[2][3] Timing is ideal amid Europe's stringent MDR regulations, as Class IIa certification positions it favorably against less rigorous competitors, capitalizing on market forces like aging populations and healthcare staffing shortages.[2] By influencing the ecosystem through scalable SaaS, UpHill enables providers to automate beyond data silos, fostering broader adoption of compliant tech in a sector projected for rapid growth.[3]
UpHill's certified platform sets it up for accelerated enterprise adoption, with potential expansion into AI-enhanced features for predictive care coordination. Trends like regulatory tightening and value-based care will amplify its edge, evolving its influence from niche innovator to ecosystem leader in European health tech. As funding fuels global scaling, expect partnerships with major providers to redefine streamlined care.
UpHill has raised $8.0M across 1 funding round. Most recently, it raised $8.0M Series A in March 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2024 | $8.0M Series A | Brighteye Ventures, Speedinvest, Nicolas Steegmann, Thibaud Elziere |